Amsterdam-founded medical imaging AI startup Aidence has landed a €10 million funding round led by INKEF Capital and Rabo Ventures, alongside existing investors Northzone, HenQ, and Health Innovations. This investment brings Aidence’s total funding to date to €12.5 million.
The company was founded in 2015 and is focused on early recognition of lung cancer by applying AI algorithms to medical imaging. Its solution, called Veye Chest, supposedly helps radiologist detect and track changes in pulmonary nodules, which can point to disease. The system is currently installed in more than 10 hospitals in the Netherlands, United Kingdom, and Scandinavia.
“With this funding, we will continue building our European market expansion while also building towards FDA clearance giving us access to the US healthcare market,” said Aidence co-founder and CEO Mark-Jan Harte.